Intra- and intergenotypic variations among human cytomegalovirus gB genotypes

Intervirology

Volumn 50, Issue 2, 2007, Pages 78-84

  Chantaraarphonkun, S ^a   Bhattarakosol, P ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

gB genotype; Genotypic variation; Human cytomegalovirus

Indexed keywords

ARTICLE; CYTOMEGALOVIRUS; DNA SEQUENCE; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE HOMOLOGY; VIRAL GENETICS; VIRUS STRAIN;

BASE SEQUENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA FINGERPRINTING; DNA, VIRAL; GENOME, VIRAL; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; THAILAND; VARIATION (GENETICS);

HUMAN HERPESVIRUS 5;

EID: 33846977703     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097393     Document Type: Article

References (28)

1. Mocarski ES: Cytomegalovirus and their replication; in Fields BN, Howley PM, Knipe DM (eds): Fields Virology. Philadelphia, Lippincott-Raven, 1996, vol 2, pp 2447-2492.
2. Ljungman P, Griffiths P, Paya C: Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002:34:1094-1097.
3. Jacobson MA, Mills J: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome. Clinical findings, diagnosis, and treatment. Ann Intern Med 1988:108:585-594.
4. Alderete JP, Jarrahian S, Geballe AP: Translational effects of mutations and polymorphisms in a repressive upstream open reading frame of the human cytomegalovirus UL4 gene. J Virol 1999:73:8330-8337.
5. Mattick C, Dewin D, Polley S, Sevilla-Reyes E, Pignatelli S, Rawlinson W, Wilkinson G, Dal Monte P, Gompels UA: Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology 2004:318:582-597.
6. Pignatelli S, Dal Monte P, Rossini G, Chou S, Gojobori T, Hanada K, Guo JJ, Rawlinson W, Britt W, Mach M, Landini MP: Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 2003:84:647-655.
7. Chou SW: Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens. J Infect Dis 1990:162:738-742.
8. Chou SW, Dennison KM: Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991:163:1229-1234.
9. Chou S: Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J Infect Dis 1992:166:604-607.
10. Bar M, Shannon-Lowe C, Geballe AP: Differentiation of human cytomegalovirus genotypes in immunocompromised patients on the basis of UL4 gene polymorphisms. J Infect Dis 2001;183:218-225.
11. Rasmussen L, Nelson M, Neff M, Merigan TC Jr: Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody. Virology 1988;163:308-318.
12. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L: Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 1993:197:143-158.
13. Navarro D, Lennette E, Tugizov S, Pereira L: Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J Med Virol 1997:52:451-459.
14. Ohizumi Y, Suzuki H, Matsumoto Y, Masuho Y, Numazaki Y: Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55. J Gen Virol 1992:73:2705-2707.
15. Meyer-Konig U, Vogelberg C, Bongarts A, Kampa D, Delbruck R, Wolff-Vorbeck G, Kirste G, Haberland M, Hufert FT, von Laer D: Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 1998:55:75-81.
16. Wada K, Mizuno S, Kato K, Kamiya T, Ozawa K: Cytomegalovirus glycoprotein B sequence variation among Japanese bone marrow transplant recipients. Intervirology 1997:40:215-219.
17. Tarrago D, Quereda C, Tenorio A: Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR. J Clin Microbiol 2003:41:2872-2877.
18. Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G: Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 2004:39:155-161.
19. Aquino VH, Figueiredo LT: High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 2000:61:138-142.
20. Qadri I, Navarro D, Paz P, Pereira L: Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J Gen Virol 1992:73:2913-2921.
21. Lambkin R, McLain L, Jones SE, Aldridge SL, Dimmock NJ: Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. J Gen Virol 1994:75:3493-3502.
22. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM: Antibody neutralization and escape by HIV-1. Nature 2003:422:307-312.
23. Smirnov YA, Gitelman AK, Govorkova EA, Lipatov AS, Kaverin NV: Influenza H5 virus escape mutants: immune protection and antibody production in mice. Virus Res 2004:99:205-208.
24. Ciurea A, Hunziker L, Zinkernagel RM, Hengartner H: Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model. Immunogenetics 2001:53:185-189.
25. Rasmussen L, Hong C, Zipeto D, Morris S, Sherman D, Chou S, Miner R, Drew WL, Wolitz R, Dowling A, Warford A, Merigan TC: Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997:175:179-184.
26. Bongarts A, Von Laer D, Vogelberg C, Ebert K, Van Lunzen J, Garweg J, Vaith P, Hufert FT, Haller O, Meyer-Konig U: Glycoprotein B genotype of human cytomegalovirus: distribution in HIV-infected patients. Scand J Infect Dis 1996:28:447-449.
27. Fries BC, Chou S, Boeckh M, Torok-Storb B: Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994:169:769-774.
28. Vogelberg C, Meyer-Konig U, Hufert FT, Kirste G, von Laer D: Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 1996:50:31-34.